CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017
Cash flows from operating activities:
Net loss from continuing operations	$ (11,731)	$ (10,700)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,223	1,138
Restructuring charges	5,615	128
Amortization of deferred financing costs	3,750	720
Deferred income taxes and noncurrent provisions	1,079	1,919
Stock-based compensation and stock warrant charges	729	2,344
Gain on sale of assets	(546)
Changes in operating assets and liabilities, net of effects from business combinations:
Accounts receivable	3,764	1,020
Other receivables	66	(1,406)
Prepaid expenses and other current assets	314	2,606
Other assets	(980)
Accounts payable	(507)	(8,838)
Other current liabilities	(7,180)	271
Deferred revenue	(1,692)	(2,990)
Net cash used in operating activities	(6,096)	(13,788)
Net cash (used in) provided by operating activities from discontinued operations	(1,380)	5,459
Cash flows from investing activities:
Capital investments	(184)	(462)
Proceeds from business disposition and sale of assets	5,643
Net cash provided by (used in) investing activities	5,459	(462)
Cash flows from financing activities:
Proceeds from term loan, subordinated promissory notes and line of credit	42,000	5,000
Payments on term loan and line of credit	(38,100)	(1,200)
Debt issuance costs	(3,016)	(300)
Payments on related party loan		(2,500)
Issuance of common stock	4	4,002
Net cash provided by financing activities	888	5,002
Decrease in cash and cash equivalents	(1,129)	(3,789)
Cash and cash equivalents, beginning of period	3,174	8,378
Cash and cash equivalents, end of period	2,045	4,589
Cash paid for:
Income taxes	837	1,039
Interest	5,238	$ 3,607
Noncash investing and financing activities:
Conversion of junior participation interests to subordinated promissory notes	$ 11,500